Carestream Molecular Imaging's Latest Gel Documentation System

Carestream Health, Inc.Performing everyday in vitro scientific imaging applications is fast and easy with Carestream Molecular Imaging's next-generation, fully automated gel imaging system. Featuring a redesigned user interface, improved look-and-feel and major productivity enhancements, including auto-focus and auto-exposure, the Gel Logic 212 PRO Imaging System enables researchers to capture perfectly exposed images in just a few clicks.

The new system is ideal for documenting and analysing fluorescent, colorimetric data in sample formats such as gels (e.g., DNA, Coomassie and silver stain), membranes and 96 well plates.

"The user-friendly, intuitive software of the Gel Logic 212 PRO makes it much easier to use than other systems I have experienced," said Brian Foster, University of Washington School of Dentistry. "I was most impressed with the flexibility of the illumination sources, which allowed us to extend the use of the system to additional assays in our lab."

The Gel Logic 212 PRO Imaging System is designed for medium-to-large labs in which workflow, high-sample throughput, safety and high-quality image analysis are critical. Key features and benefits include:

  • True 12-bit data capture - Scientific-grade, 1.4 million-pixel CCD camera can accumulate up to 12 bits of data, resulting in more detail and higher accuracy. Researchers can detect and quantify very dim as well as very bright signals (e.g. bands) in the same image.
  • Auto-focus and easy-illumination - Focuses perfectly on samples with exposure levels automatically adjusted to optimise image quality without saturations. Lighting options are motorised, enabling illumination to be quickly adjusted via virtual controls.
  • Motorised lens with 6x zoom - An 8-48mm motorised lens combines with a 1.4 mega-pixel CCD to offer automated focus and excellent resolution for small sample imaging.
  • Available white light trans-illuminator - LED-based white light source offers high uniformity and strong adjustable illuminations of samples.

"We redesigned our core gel documentation system from the ground up, with the aim of making fundamental imaging applications that researchers perform every day easier and more reliable," said Craig Smith, Global Product Manager, In Vitro Systems, Carestream Molecular Imaging. "It delivers superb image quality, high performance and ease-of-use not previously seen in this class of gel documentation systems-all at an affordable price."

The system will also be upgradeable for imaging a wider array of samples including chemiluminescence, fluorescence, and chromogenic gels, blots, and plates. All Carestream Molecular Imaging Gel Logic systems ship with Carestream Molecular Imaging Software to optimise performance and quantitative analysis capabilities. For more information including a full list of features and benefits, visit www.carestreamhealth.com/gel-logic-systems.html.

About Carestream Molecular Imaging
Carestream Molecular Imaging group, a division of Carestream Health, Inc., develops and markets high performance digital imaging systems, imaging agents, film and accessories under the KODAK brand for the life science research and drug discovery/development market segments. For more information, visit http://mi.carestreamhealth.com.

Related news articles:

About Carestream Health, Inc.
Formed in 2007, Carestream Health, Inc., is a worldwide provider of dental and medical imaging systems and healthcare IT solutions; molecular imaging systems for the life science research and drug discovery/development market segments; and X-ray film and digital X-ray products for the non-destructive testing market. For more information about the company's broad portfolio of products, solutions and services, please contact your Carestream Health representative or visit www.carestreamhealth.com.

CARESTREAM is a trademark of Carestream Health, Inc.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...